EUVIMEDEUVIMED entdecken
Crossref

Expression and diagnostic value of interleukin-22 in rheumatoid arthritis-associated interstitial lung disease

Quanquan Fang, Jingzhi Xie, Juan Zong, Yu Zhou, Qin Zhou, Songlou Yin, Lina Cao, Hanqiu Yin, Dongmei Zhou

International Immunopharmacology · 2024-06 · 134 · 112173

DOI: 10.1016/j.intimp.2024.112173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-06. Verfasst von Quanquan Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221005, Jiangsu Province, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Biomarkers, Interleukin-22, Interleukins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is characterized by a high incidence and mortality rate, highlighting the need for biomarkers to detect ILD early in RA patients. Previous studies have shown the protective effects of Interleukin-22 (IL-22) in pulmonary fibrosis using mouse models. This study aims to assess IL-22 expression in RA-ILD to validate foundational experiments and explore its diagnostic value. The study included 66 newly diagnosed RA patients (33 with ILD, 33 without ILD) and 14 healthy controls (HC). ELISA was utilized to measure IL-22 levels and perform intergroup comparisons. The correlation between IL-22 levels and the severity of RA-ILD was examined. Logistic regression analysis was employed to screen potential predictive factors for RA-ILD risk and establish a predictive nomogram. The diagnostic value of IL-22 in RA-ILD was assessed using ROC. Subsequently, the data were subjected to 30-fold cross-validation. IL-22 levels in the RA-ILD group were lower than in the RA-No-ILD group and were inversely correlated with the severity of RA-ILD. Logistic regression analysis identified IL-22, age, smoking history, anti-mutated citrullinated vimentin antibody (MCV-Ab), and mean corpuscular hemoglobin concentration (MCHC) as independent factors for distinguishing between the groups. The diagnostic value of IL-22 in RA-ILD was moderate (AUC = 0.75) and improved when combined with age, smoking history, MCV-Ab and MCHC (AUC = 0.97). After 30-fold cross-validation, the average AUC was 0.886. IL-22 expression is dysregulated in the pathogenesis of RA-ILD. This study highlights the potential of IL-22, along with other factors, as a valuable biomarker for assessing RA-ILD occurrence and progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidBiomarkersInterleukin-22InterleukinsLung Diseases, InterstitialAdultAgedFemaleHumansMaleMiddle Aged

Stichwörter der Autor:innen

Interleukin 22Rheumatoid arthritisRheumatoid arthritis-associated interstitial lung disease

Substanzen

BiomarkersInterleukin-22InterleukinsIL22 protein, human

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221005, Jiangsu Province, China.
  • School of Mathematics and Statistics, Jiangsu Normal University, Xuzhou 221116, Jiangsu Province, China.
  • Department of Rheumatology and Immunology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221005, Jiangsu Province, China. Electronic address: yhqxyfy@outlook.com.
  • Department of Rheumatology and Immunology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221005, Jiangsu Province, China. Electronic address: zdm@xzhmu.edu.cn.

Zitieren

APA

Fang, Q., Xie, J., Zong, J., Zhou, Y., Zhou, Q., Yin, S., Cao, L., Yin, H., & Zhou, D. (2024). Expression and diagnostic value of interleukin-22 in rheumatoid arthritis-associated interstitial lung disease. International Immunopharmacology, 134, 112173. https://doi.org/10.1016/j.intimp.2024.112173

Vancouver

Fang Q, Xie J, Zong J, Zhou Y, Zhou Q, Yin S, et al. Expression and diagnostic value of interleukin-22 in rheumatoid arthritis-associated interstitial lung disease. International Immunopharmacology. 2024;134:112173. doi:10.1016/j.intimp.2024.112173

BibTeX
@article{Fang2024,
  author = {Fang, Quanquan and Xie, Jingzhi and Zong, Juan and Zhou, Yu and Zhou, Qin and Yin, Songlou and Cao, Lina and Yin, Hanqiu and Zhou, Dongmei},
  title = {Expression and diagnostic value of interleukin-22 in rheumatoid arthritis-associated interstitial lung disease},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {134},
  pages = {112173},
  doi = {10.1016/j.intimp.2024.112173}
}
Kostenlos starten →